申请人:Schultz Melanie
公开号:US20120015976A1
公开(公告)日:2012-01-19
The present invention relates to compounds according to formula (I) as autotaxin inhibitors and the use of such compounds for the treatment and/or prophylaxis of physiological and/or pathophysiological conditions, which are caused, mediated and/or propagated by increased lysophosphatic acid levels and/or the activation of autotaxin, in particular of different cancers.
本发明涉及公式(I)的化合物,作为自体税脂酰酰肽酶抑制剂,并且利用这种化合物治疗和/或预防由升高的溶解磷脂酸水平和/或自体税脂酰酰肽酶的激活引起、介导和/或传播的生理和/或病理生理状况,特别是不同癌症。